コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e 1, juvenile diabetes) or relative (type 2, maturity-onset diabetes).
2 diseases including the systemic amyloidoses, maturity onset diabetes, Alzheimer's disease and transmi
3 on 17q12, previously shown to be mutated in maturity-onset diabetes, as well as in a subset of pedia
4 the glucokinase gene have been identified in maturity onset diabetes in the young, a particular form
5 etes by employing a mouse model (GENA348) of Maturity Onset Diabetes in the Young, exhibiting hypergl
9 s developed diabetes with characteristics of maturity onset diabetes of the young (MODY), regardless
15 ctively: defects in Pdx-1 or HNF4alpha cause maturity onset diabetes of the young (MODY4 and 1, respe
16 x 1 (Pdx1) are associated with both T2DM and maturity onset diabetes of the young (MODY4), and low le
17 ons in HNF4A were identified as the cause of Maturity Onset Diabetes of the Young 1 (MODY1) two decad
20 KLF) transcription factor, mutated in French maturity onset diabetes of the young patients (MODY7), r
21 ndividuals with an extreme form of diabetes (maturity onset diabetes of the young type 1, caused by m
22 lian glucose sensor that is mutated in human maturity onset diabetes of the young type 2 and the targ
23 or 1-alpha (HNF1A), the gene responsible for maturity onset diabetes of the young type 3 (MODY3).
24 uclear factor-1alpha (HNF-1alpha) gene cause maturity onset diabetes of the young type 3, a form of t
25 r-beta-inducible early gene 2) and MODY VII (maturity onset diabetes of the young VII), regulates tra
26 form of diabetes and suggest that KPD, like maturity onset diabetes of the young, is a rare, phenoty
27 odenal homeobox 1 (PDX1) are associated with maturity onset diabetes of the young, type 4 (MODY4) and
34 in the VNTR (CEL14R) or C563fsX673 CEL (CEL maturity onset diabetes of youth with a deletion mutatio
35 lycemia or hyperglycemia associated with GCK-maturity-onset diabetes of the young (GCK-MODY), collect
36 (euinsulinemia and euglycemia), glucokinase-maturity-onset diabetes of the young (GCK-MODY; euinsuli
37 been recently noted in some individuals with maturity-onset diabetes of the young (MODY) and in some
38 rious forms of monogenic diabetes, including maturity-onset diabetes of the young (MODY) and PND (HNF
39 wn to cause two specific monogenic diseases: maturity-onset diabetes of the young (MODY) and severe d
40 y-onset diabetes, such as neonatal diabetes, maturity-onset diabetes of the young (MODY) and various
41 MODY3) account for the largest proportion of maturity-onset diabetes of the young (MODY) cases in the
42 tive distribution of the 90 families fitting maturity-onset diabetes of the young (MODY) criteria was
43 genic diabetes is typically for mutations in maturity-onset diabetes of the young (MODY) genes that p
45 t to which common variation in the six known maturity-onset diabetes of the young (MODY) genes, which
46 a monogenic form of diabetes that resembles maturity-onset diabetes of the young (MODY) in many resp
56 associated with MODY with reduced penetrance.Maturity-onset diabetes of the young (MODY) is the most
57 ave suggested that variants in the genes for maturity-onset diabetes of the young (MODY) may confer s
58 ht to identify INS mutations associated with maturity-onset diabetes of the young (MODY) or nonautoim
59 tability GK mutants that explain in part the maturity-onset diabetes of the young (MODY) phenotype in
62 loss-of-function HNF1A mutations causal for maturity-onset diabetes of the young (MODY) would displa
63 e encoding this enzyme are a common cause of maturity-onset diabetes of the young (MODY), a form of n
65 sed before 2 years of age, 296 probands with maturity-onset diabetes of the young (MODY), and 463 pat
66 ronmental contexts, HNF1A variants can cause maturity-onset diabetes of the young (MODY), increase ty
67 tor (HNF)-1beta are the cause of one form of maturity-onset diabetes of the young (MODY), type 5 (MOD
69 clear factor (HNF)-4alpha are known to cause maturity-onset diabetes of the young (MODY), which is ch
80 se a mild hereditary form of diabetes termed maturity-onset diabetes of the young (MODY)2 or GCK-MODY
81 nd HNF-1beta are the causes of four forms of maturity-onset diabetes of the young (MODY1 and 3-5, res
82 HNF4A variants are commonly associated with maturity-onset diabetes of the young (MODY1; HNF4A-MODY)
85 s in the HNF-1alpha gene are responsible for maturity-onset diabetes of the young (MODY3), which is c
88 pha gene are responsible for the inheritable maturity-onset diabetes of the young 1 (MODY-1), support
90 s in the HNF-4alpha gene are responsible for maturity-onset diabetes of the young 1 (MODY1), which is
93 ariants in the HNF1A gene are known to cause maturity-onset diabetes of the young 3 (MODY3 or HNF1A M
98 in two forms of early-onset type 2 diabetes (maturity-onset diabetes of the young [MODY]), MODY3 and
100 uclear factor (HNF)-4alpha gene (RW pedigree/maturity-onset diabetes of the young [MODY]-1) have dimi
101 nuclear factor (HNF)-1alpha gene mutations (maturity-onset diabetes of the young [MODY]-3) is charac
102 e six genes causing the most common forms of maturity-onset diabetes of the young allows us to infer
105 r factor 1alpha (HNF-1A) are associated with maturity-onset diabetes of the young form 3 (MODY 3) and
107 were analyzed in 1,676 patients referred for maturity-onset diabetes of the young genetic testing.
108 (INS-PND) or the HNF1B gene associated with maturity-onset diabetes of the young had smaller pancrea
109 ely that chromosome 10p12.1-p13 may harbor a maturity-onset diabetes of the young or type 2 diabetes
112 GK and several mutant forms associated with maturity-onset diabetes of the young type 2 (MODY-2) wer
113 potent stem cells (iPSCs) from subjects with maturity-onset diabetes of the young type 2 (MODY2), whi
115 Mutations in HNF-1alpha are associated with maturity-onset diabetes of the young type 3 (MODY3), and
117 e nuclear factor 1alpha (HNF-1alpha) lead to maturity-onset diabetes of the young type 3 as a result
119 in the human HNF1B gene are associated with maturity-onset diabetes of the young type 5 (MODY5) and
120 omal dominant mutations of HNF-1beta develop maturity-onset diabetes of the young type 5 (MODY5) and
122 several potentially fatal diseases including maturity-onset diabetes of the young type II (MODY-II) a
123 d increased T2D risk, previously reported in maturity-onset diabetes of the young with reduced penetr
124 QT syndrome, and glycosylated hemoglobin for maturity-onset diabetes of the young) provide evidence f
125 le for monogenic forms of diabetes (notably, maturity-onset diabetes of the young), and, in patients
127 e metabolic genes, have been correlated with maturity-onset diabetes of the young, a monogenic form o
130 etes, including common and uncommon types of maturity-onset diabetes of the young, multiple causes of
131 are suspected or known to be associated with maturity-onset diabetes of the young, one is a gene-dese
132 dentified for rate monogenic forms of NIDDM: maturity-onset diabetes of the young, or MODY (which is
133 HNF-4alpha protein mutations are linked to maturity-onset diabetes of the young, type 1 (MODY1) and
134 uclear factor (HNF)-4alpha gene give rise to maturity-onset diabetes of the young, type 1 (MODY1).
135 at influence several human traits, including maturity-onset diabetes of the young, type 2 diabetes, l
138 ) or fourth (DEL4) VNTR segment of CEL cause maturity-onset diabetes of the young, type 8 (MODY8), an
139 f1 are associated with human diseases MODY5 (maturity-onset diabetes of the young, type V) and famili
147 of non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young; gene named MODY1).
148 T1D-GRS was highly discriminative of proven maturity-onset diabetes of young (MODY) (n = 805) and T1
149 >G) are linked to: T2D, depression, anxiety, maturity-onset-diabetes-of the young 3/MODY3, obesity, w